ChristiansenKJBernardEMGoldJWMArmstrongD. Distribution and activity of amphotericin B in humans. J Infect Dis1985; 152: 1037–43.
2.
AtkinsonAJBennettJE. Amphotericin B pharmacokinetics in humans. Antimicrob Agents Chemother1978; 13: 271–6.
3.
BindschadlerDDBennettJE. A pharmacologic guide to the clinical use of amphotericin B. J Infect Dis1969; 120: 427–36.
4.
ChesneyPJTeetsKCMulvihillJJSalitIEMarksMI. Successful treatment of Candida meningitis with amphotericin B and 5-fluorocytosine in combination. J Pediatr1976; 89: 1017–9.
5.
WardRMSalterFRDaltonAS. Assessment of antifungal therapy in an 800-gram infant with candidal arthritis and osteomyelitis. Pediatrics1983; 72: 234–8.
6.
BaleyJMeyersCKliegmanREdwardRJacobsMBlumerJ. Pharmacokinetics of amphotericin B and 5-fluorocytosine in neonates (abstract). Pediatr Res1986; 20: 201.
7.
Drugs for treatment of systemic fungal infections. Med Lett Drugs Ther1986; 28: 41–4.
8.
CherryJDLloydCAQuiltyJFLaskowskiLF. Amphotericin B therapy in children: A review of the literature and a case report. J Pediatr1969; 75: 1063–9.
9.
MedoffGComfortMKobayashiGS. Synergistic action of amphotericin B and 5-fluorocytosine against yeast-like organisms. Proc Soc Exp Biol Med1971; 138: 571–4.
10.
MedoffGKobayashiGSKwanCNSchlessingerDVerkovP. Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B. Proc Natl Acad Sci USA1972; 69: 196–9.
11.
RobinovitchSShawBDBryantTDontaST. Effect of 5-fluorocytosine and amphotericin B on Candida albicans infections in mice. J Infect Dis1974; 130: 28–31.
12.
BennettJEDismukesWEDumaJR. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis. N Engl J Med1979; 301: 126–31.
13.
BennettJE. Flucytosine. Ann Intern Med1977; 86: 319–22.
14.
MedoffGKobayashiGS. Strategies in the treatment of fungal infections. N Engl J Med1980; 302: 145–55.
